BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 26938814)

  • 1. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension: results from the PREVER-treatment randomized trial.
    Fuchs FD; Scala LC; Vilela-Martin JF; de Mello RB; Mosele F; Whelton PK; Poli-de-Figueiredo CE; de Alencastro PR; E Silva RP; Gus M; Bortolotto LA; Schlatter R; Cesarino EJ; Castro I; Neto JA; Chaves H; Steffens AA; Alves JG; Brandão AA; de Sousa MR; Jardim PC; Moreira LB; Franco RS; Gomes MM; Neto AA; Fuchs FC; Filho DC; Nóbrega AC; Nobre F; Berwanger O; Fuchs SC
    J Hypertens; 2016 Apr; 34(4):798-806. PubMed ID: 26938814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of chlorthalidone/amiloride versus losartan in patients with stage I hypertension and diabetes mellitus: results from the PREVER-treatment randomized controlled trial.
    Fuchs FD; Scala LCN; Vilela-Martin JF; Whelton PK; Poli-de-Figueiredo CE; Pereira E Silva R; Gus M; Bortolotto LA; Consolim-Colombo FM; Schlatter RP; Cesarino JE; Castro I; Figueiredo Neto JA; Chaves H; Steffens AA; Alves JG; Brandão AA; de Sousa MR; Jardim PC; Moreira LB; Franco RS; Gomes MM; Afiune Neto A; Fuchs FC; Sobral Filho DC; Nóbrega AC; Nobre F; Berwanger O; Fuchs SC
    Acta Diabetol; 2021 Feb; 58(2):215-220. PubMed ID: 33047257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Fixed-dose Combinations of Amlodipine/Losartan Potassium/Chlorthalidone and Amlodipine/Losartan Potassium in Patients With Stage 2 Hypertension Inadequately Controlled With Amlodipine/Losartan Potassium: A Randomized, Double-blind, Multicenter, Phase III Study.
    Hong SJ; Jeong HS; Han SH; Chang KY; Hong BK; Lee BK; Chae SC; Kim WS; Park CG; Heo JH; Lee SU; Kim YD; Kim KS; Choi JH; Kang HJ; Kim JJ; Kang SM; Choi YJ; Shin JH; Chun KJ; Shin DG; Park SH; Kwan J; Choi YJ; Jeong MH; Chae JK; Kim DW; Cho JR; Han KR; Won KH; Park SH; Lee SK; Kim SH; Jung J; Kim CH
    Clin Ther; 2017 Oct; 39(10):2049-2060. PubMed ID: 28939406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effectiveness of Chlorthalidone Plus Amiloride for the Prevention of Hypertension: The PREVER-Prevention Randomized Clinical Trial.
    Fuchs SC; Poli-de-Figueiredo CE; Figueiredo Neto JA; Scala LC; Whelton PK; Mosele F; de Mello RB; Vilela-Martin JF; Moreira LB; Chaves H; Mota Gomes M; de Sousa MR; Silva RP; Castro I; Cesarino EJ; Jardim PC; Alves JG; Steffens AA; Brandão AA; Consolim-Colombo FM; de Alencastro PR; Neto AA; Nóbrega AC; Franco RS; Sobral Filho DC; Bordignon A; Nobre F; Schlatter R; Gus M; Fuchs FC; Berwanger O; Fuchs FD
    J Am Heart Assoc; 2016 Dec; 5(12):. PubMed ID: 27965209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison between diuretics and angiotensin-receptor blocker agents in patients with stage I hypertension (PREVER-treatment trial): study protocol for a randomized double-blind controlled trial.
    Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortolotto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Afiune Neto A; Scala LC; Mota M; Chaves H; Alves JG; Sobral Filho DC; Pereira e Silva R; Figueiredo Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
    Trials; 2011 Feb; 12():53. PubMed ID: 21349192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Echocardiographic Left Ventricular Reverse Remodeling After 18 Months of Antihypertensive Treatment in Stage I Hypertension. Results From the Prever-Treatment Study.
    Bertoluci C; Foppa M; Santos ABS; Branchi TV; Fuchs SC; Fuchs FD
    Am J Hypertens; 2018 Feb; 31(3):321-328. PubMed ID: 29036504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diuretics are Similar to Losartan on Echocardiographic Target-Organ Damage in Stage I Hypertension. PREVER-Treatment Study.
    Bertoluci C; Foppa M; Santos ABS; Fuchs SC; Fuchs FD
    Arq Bras Cardiol; 2019 Jan; 112(1):87-90. PubMed ID: 30673020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study.
    Hong SJ; Sung KC; Lim SW; Kim SY; Kim W; Shin J; Park S; Kim HY; Rhee MY;
    Drug Des Devel Ther; 2020; 14():5735-5746. PubMed ID: 33408462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of low-dose diuretics for blood pressure reduction to optimal values in prehypertension: a randomized clinical trial.
    Fuchs FD; Fuchs SC; Poli-de-Figueiredo CE; Figueiredo Neto JA; Scala LCN; Vilela-Martin JF; Moreira LB; Chaves H; Mota Gomes M; de Sousa MR; Silva RPE; Castro I; Cesarino EJ; Sousa ALL; Alves JG; Steffens AA; Brandão AA; Bortolotto LA; Afiune Neto A; Nóbrega AC; Franco RS; Sobral Filho DC; Nobre F; Schlatter R; Gus M; De David CN; Rafaelli L; Sesin GP; Berwanger O; Whelton PK
    J Hypertens; 2018 Apr; 36(4):933-938. PubMed ID: 29227377
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of chlorthalidone plus amiloride compared with amlodipine on short-term blood pressure variability in individuals with hypertension and obstructive sleep apnea: a randomized controlled trial.
    Lucca MB; Jorge JA; Cichelero FT; Martinez D; Borges RB; Hirakata VN; Fuchs FD; Fuchs SC
    Blood Press Monit; 2023 Dec; 28(6):289-294. PubMed ID: 37466401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of hypertension in patients with pre-hypertension: protocol for the PREVER-prevention trial.
    Fuchs FD; Fuchs SC; Moreira LB; Gus M; Nóbrega AC; Poli-de-Figueiredo CE; Mion D; Bortoloto L; Consolim-Colombo F; Nobre F; Coelho EB; Vilela-Martin JF; Moreno H; Cesarino EJ; Franco R; Brandão AA; de Sousa MR; Ribeiro AL; Jardim PC; Neto AA; Scala LC; Mota M; Chaves H; Alves JG; Filho DC; Pereira e Silva R; Neto JA; Irigoyen MC; Castro I; Steffens AA; Schlatter R; de Mello RB; Mosele F; Ghizzoni F; Berwanger O
    Trials; 2011 Mar; 12():65. PubMed ID: 21375762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of antihypertensive agents on sleep apnea and ambulatory blood pressure in patients with hypertension: A randomized controlled trial.
    Cichelero FT; Fuchs SC; Jorge JA; Martinez D; Oliveira GPF; Lucca MB; Oliveira ACT; Fuchs FD
    Sleep Med; 2024 Jul; 119():417-423. PubMed ID: 38781664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The antihypertensive and biochemical effects of hydrochlorothiazide/amiloride (Moduretic) versus chlorthalidone.
    van Soeren F
    J Int Med Res; 1980; 8(2):132-5. PubMed ID: 6989682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, comparative study evaluating the efficacy and tolerability of losartan-low dose chlorthalidone (6.25 mg) combination with losartan-hydrochlorothiazide (12.5 mg) combination in Indian patients with mild-to-moderate essential hypertension.
    Pareek A; Basavanagowdappa H; Zawar S; Kumar A; Chandurkar N
    Expert Opin Pharmacother; 2009 Jul; 10(10):1529-36. PubMed ID: 19514864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood pressure-lowering efficacy of amiloride versus enalapril as add-on drugs in patients with uncontrolled blood pressure receiving hydrochlorothiazide.
    Guerrero P; Fuchs FD; Moreira LM; Martins VM; Bertoluci C; Fuchs SC; Gus M
    Clin Exp Hypertens; 2008 Oct; 30(7):553-64. PubMed ID: 18855259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to prevent heart attack trial (ALLHAT). ALLHAT Collaborative Research Group.
    JAMA; 2000 Apr; 283(15):1967-75. PubMed ID: 10789664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Barzilay JI; Davis BR; Cutler JA; Pressel SL; Whelton PK; Basile J; Margolis KL; Ong ST; Sadler LS; Summerson J;
    Arch Intern Med; 2006 Nov; 166(20):2191-201. PubMed ID: 17101936
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the efficacy and safety of fixed-dose amlodipine/losartan and losartan in hypertensive patients inadequately controlled with losartan: a randomized, double-blind, multicenter study.
    Hong BK; Park CG; Kim KS; Yoon MH; Yoon HJ; Yoon JH; Yang JY; Choi YJ; Cho SY
    Am J Cardiovasc Drugs; 2012 Jun; 12(3):189-95. PubMed ID: 22462558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood pressure reduction and antihypertensive medication use in the losartan intervention for endpoint reduction in hypertension (LIFE) study in patients with hypertension and left ventricular hypertrophy.
    Devereux RB; de Faire U; Fyhrquist F; Harris KE; Ibsen H; Kjeldsen SE; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H; Hille DA; Dahlöf B
    Curr Med Res Opin; 2007 Feb; 23(2):259-70. PubMed ID: 17288679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antihypertensive efficacy of hydrochlorothiazide vs chlorthalidone combined with azilsartan medoxomil.
    Bakris GL; Sica D; White WB; Cushman WC; Weber MA; Handley A; Song E; Kupfer S
    Am J Med; 2012 Dec; 125(12):1229.e1-1229.e10. PubMed ID: 22939358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.